TipRanks
Go Ultimate55% OFF

Vita Coco Company (85E) AI Stock Analysis

DE:85E

Vita Coco Company

(XETRA:85E)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Revenue growth and margin expansionThe combination of sustained revenue expansion and materially higher margins indicates improving scale and operating execution. A stronger earnings base gives Vita Coco greater capacity to fund brand investment, innovation, and distribution while supporting durable profitability over the next several quarters.
Negative Factors
Capacity constraints may limit near-term growthHigh utilization and constrained Copra capacity may prevent the company from fully converting strong retail demand into shipments and revenue. Although additions are planned, the timing creates an execution bottleneck that could limit growth, reduce service levels, and delay the benefits of expansion during the next several quarters.

Vita Coco Company (85E) vs. iShares MSCI Germany ETF (EWG)

-25%0%25%50%75%100%125%DE:85E+49.97%EWG+4.43%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
EUR 3.34B
Dividend Yield
―
Average Volume (3M)
106
Price to Earnings (P/E)
27.8
Beta (1Y)
0.38
Revenue Growth
20.53%
EPS Growth
66.62%
Country
Germany
Employees
336
Sector
Consumer Defensive
Sector Strength
62
Industry
Beverages - Non-Alcoholic

Vita Coco Company Business Overview & Revenue Model

Company Description

The Vita Coco Company, Inc. is a global beverage enterprise, founded in New York in 2004, primarily engaged in the development, marketing, and distribution of its flagship Vita Coco-branded coconut water. Its extensive market presence spans the Unite...

Vita Coco Company Earnings Call Summary

Earnings Call Date:Oct 21, 2026(Q3-2026)|% Change Since:-5.70%|Next Earnings Date:Mar 10, 2027
Earnings Call SentimentPositive

The call was strongly positive overall. Management reported robust category, brand, international, private label, profitability, cash generation, and guidance trends, while expressing high confidence in the Copra integration and long-term growth opportunity. The principal challenges were supply-chain execution, container and port congestion, near-term capacity constraints, higher transportation and input costs, and an expected fourth-quarter gross margin decline to approximately 33%.

Positive Updates

Strong Third-Quarter Net Sales Growth
Third-quarter net sales increased 34% year over year to $244 million, driven by Vita Coco coconut water net sales growth of 15% and private label growth of 152%. Organic growth was 18%, with Copra contributing $29 million in the Americas.

Negative Updates

Reduced Service Levels and Deferred Shipments
Demand for both branded and private label products exceeded projections, tightening the supply chain during the quarter. Reduced service levels caused shipments to lag continued strong retail scan growth, and management said the company did not ship all of the product customers wanted, resulting in deferred sales.

Company Guidance

The company said it is too early to provide financial guidance for 2027, but expects supply to support a continuation of current volume growth trends into next year and beyond, with capacity utilization remaining high early in 2027, the first 6 months running at 95% utilization, capacity additions coming on mid next year, constraints falling away a little by Q4 of next year, and a preferred 85% utilization model in 2028; for 2026, it expects net sales between $810 million and $820 million, gross margins for the full year of approximately 40%, and adjusted EBITDA of $170 million to $175 million, based on the U.S. category growing in the mid-20s, international business maintaining very healthy growth rates, consolidated Vita Coco coconut water net sales growth of approximately low 20%, U.S. Vita Coco net sales growing in the high teens, and U.S. private label net sales growth of 110%-120%; Q4 gross margins are expected to be approximately 33%, SG&A leverage approximately 1.5 points as a percentage of sales, and long term gross margin aspirations remain unchanged in the high 30s, approaching 40%, with pricing increases taking effect in Q1 of 2027.

Vita Coco Company Risk Analysis

Vita Coco Company disclosed 46 risk factors in its most recent earnings report. Vita Coco Company reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

2 New Risks
1.Ownership and operation of manufacturing facilities subjects us to risks not previously associated with our asset-light business model.Q2, 2026
2.The ongoing military conflict involving Iran and related disruption in the Middle East, may adversely affect our business, supply chain, financial condition, and results of operations.Q2, 2026

Vita Coco Company Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

DE:85E against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
KOKO79Outperform$404.72B27.6742.00%2.23%7.74%12.29%
FIZZFIZZ66Neutral$3.30B18.9832.60%―-1.80%-5.87%
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%
ZVIAZVIA57Neutral$92.04M-8.93-19.05%―7.22%42.48%
CELHCELH56Neutral$7.37B138.674.36%―82.86%-35.81%
SUJASUJA46Neutral$411.36M56.055.65%―――

* Consumer Defensive Sector Average

Performance Comparison

-50%0%50%100%DE:85EKOFIZZCELHZVIASUJADec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
DE:85E and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:85EVita Coco Company, Inc.52.2816.8147.39%
KOCoca-cola Company94.0827.8742.10%
FIZZNational Beverage35.305.2217.35%
CELHCelsius Holdings29.12-30.13-50.85%
ZVIAZevia Pbc Class A1.19-1.19-50.00%
SUJASuja Life, Inc. Class A10.65-7.20-40.34%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.